BANK OF AMERICA CORP /DE/ - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 335 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$34,038,302
+156.3%
2,200,278
+160.3%
0.00%
+300.0%
Q2 2023$13,281,630
-37.9%
845,425
-34.8%
0.00%
-50.0%
Q1 2023$21,371,880
+59.9%
1,296,837
+51.4%
0.00%0.0%
Q4 2022$13,366,663
-7.1%
856,837
-22.8%
0.00%0.0%
Q3 2022$14,387,000
+21.0%
1,109,256
+31.0%
0.00%
+100.0%
Q2 2022$11,887,000
-75.5%
846,615
-75.0%
0.00%
-80.0%
Q1 2022$48,515,000
+12.8%
3,387,908
+7.3%
0.01%
+25.0%
Q4 2021$43,026,000
-35.4%
3,156,640
-22.4%
0.00%
-42.9%
Q3 2021$66,626,000
+84.0%
4,067,496
+89.1%
0.01%
+75.0%
Q2 2021$36,207,000
-25.5%
2,151,354
-19.2%
0.00%
-20.0%
Q1 2021$48,601,000
+38.3%
2,661,644
+37.9%
0.01%0.0%
Q4 2020$35,136,000
-38.4%
1,930,518
-39.7%
0.01%
-37.5%
Q3 2020$57,069,000
+2.7%
3,198,957
+3.3%
0.01%0.0%
Q2 2020$55,546,000
+19.4%
3,097,963
+1.1%
0.01%0.0%
Q1 2020$46,519,000
-40.4%
3,064,504
-22.6%
0.01%
-27.3%
Q4 2019$78,116,000
+12.2%
3,959,252
-2.2%
0.01%
+10.0%
Q3 2019$69,605,000
+5.1%
4,046,879
+8.1%
0.01%0.0%
Q2 2019$66,240,000
+35.4%
3,742,366
+55.8%
0.01%
+25.0%
Q1 2019$48,920,000
-57.8%
2,401,594
-65.2%
0.01%
-60.0%
Q4 2018$116,033,0006,898,4730.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders